Shandong Jincheng Pharmaceutical and Chemical Co Ltd (SHE:300233) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (SHE:300233) has a market capitalization of $871.80 Million (CN¥5.96 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #9740 globally and #2739 in its home market, demonstrating a -3.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Jincheng Pharmaceutical and Chemical Co Ltd's stock price CN¥15.52 by its total outstanding shares 383874587 (383.87 Million). Analyse cash flow conversion of Shandong Jincheng Pharmaceutical and Che to see how efficiently the company converts income to cash.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Market Cap History: 2015 to 2026
Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.68 Billion to $871.80 Million (-6.03% CAGR).
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.20x
Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.43x
Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap is 3.43 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.68 Billion | $1.18 Billion | $170.98 Million | 1.43x | 9.84x |
| 2016 | $1.26 Billion | $1.42 Billion | $159.39 Million | 0.89x | 7.92x |
| 2017 | $971.53 Million | $2.79 Billion | $286.30 Million | 0.35x | 3.39x |
| 2018 | $719.00 Million | $3.01 Billion | $263.86 Million | 0.24x | 2.72x |
| 2019 | $1.06 Billion | $2.79 Billion | $203.28 Million | 0.38x | 5.21x |
| 2020 | $1.03 Billion | $2.96 Billion | -$488.85 Million | 0.35x | N/A |
| 2021 | $1.58 Billion | $3.14 Billion | $107.98 Million | 0.50x | 14.62x |
| 2022 | $1.24 Billion | $3.51 Billion | $273.37 Million | 0.36x | 4.55x |
| 2023 | $917.62 Million | $3.54 Billion | $174.71 Million | 0.26x | 5.25x |
| 2024 | $674.08 Million | $3.37 Billion | $196.78 Million | 0.20x | 3.43x |
Competitor Companies of 300233 by Market Capitalization
Companies near Shandong Jincheng Pharmaceutical and Chemical Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Shandong Jincheng Pharmaceutical and Chemical Co Ltd by market ranking:
- BASF SE (F:BASA): Ranked #536 globally with a market cap of $49.38 Billion USD ( €42.24 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #575 globally with a market cap of $45.45 Billion USD ( €38.87 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #802 globally with a market cap of $32.94 Billion USD ( CN¥225.13 Billion CNY).
- Hengli Petrochemical Co Ltd (SHG:600346): Ranked #1121 globally with a market cap of $22.75 Billion USD ( CN¥155.49 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #536 | BASF SE | F:BASA | $49.38 Billion | €13.80 |
| #575 | BASF SE | XETRA:BAS | $45.45 Billion | €54.74 |
| #802 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $32.94 Billion | CN¥30.70 |
| #1121 | Hengli Petrochemical Co Ltd | SHG:600346 | $22.75 Billion | CN¥22.09 |
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Jincheng Pharmaceutical and Chemical Co Ltd's market cap moved from $1.68 Billion to $ 871.80 Million, with a yearly change of -6.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥871.80 Million | +10.94% |
| 2025 | CN¥785.86 Million | +16.58% |
| 2024 | CN¥674.08 Million | -26.54% |
| 2023 | CN¥917.62 Million | -26.29% |
| 2022 | CN¥1.24 Billion | -21.16% |
| 2021 | CN¥1.58 Billion | +53.98% |
| 2020 | CN¥1.03 Billion | -3.16% |
| 2019 | CN¥1.06 Billion | +47.29% |
| 2018 | CN¥719.00 Million | -25.99% |
| 2017 | CN¥971.53 Million | -23.06% |
| 2016 | CN¥1.26 Billion | -24.94% |
| 2015 | CN¥1.68 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Shandong Jincheng Pharmaceutical and Chemical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $871.80 Million USD |
| MoneyControl | $871.80 Million USD |
| MarketWatch | $871.80 Million USD |
| marketcap.company | $871.80 Million USD |
| Reuters | $871.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Jincheng Pharmaceutical and Chemical Co Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.